Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Politicians who traded IBRX

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
1
Filings
1
Politicians
1
Buys / sells
0 / 1
Estimated volume
$8.00K
Sum of range midpoints
Politicians who traded IBRX
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Daniel S. Goldman House · NY
10 / 1$8.00KMar 6, 2023Apr 17, 2023

Trades

Reported trades in ImmunityBio, Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Daniel S. Goldman House · NY
IBRXImmunityBio, Inc.SellSelfMar 6, 2023Apr 17, 202342 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.